delivery technologies. They target early-stage innovation on the transition of preclinical proof-of-concept or validation and provides seed funding and work actively with inventors, entrepreneurs, and institutions to devise and implement development and commercialization strategies, assemble management teams, and secure additional capital. It aims to leverage their collective experience and industry network to achieve early exits that generate attractive, risk-mitigated financial returns.

Peng Fu established the firm in Toronto, Ontario in 2015.